What is the recommended dosage of cilostazol for an adult with intermittent claudication, including any adjustments for renal or hepatic impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Cilostazol Dosage

The recommended dosage of cilostazol for adults with intermittent claudication is 100 mg orally twice daily, taken 30 minutes before or 2 hours after breakfast and dinner. 1, 2, 3, 4

Standard Dosing

  • 100 mg twice daily is the established therapeutic dose
  • Taken 30 minutes before or 2 hours after meals (breakfast and dinner) 4
  • The 100 mg twice daily dose is more effective than 50 mg twice daily 1
  • Clinical benefit typically appears within 2-4 weeks, with continued improvement over 12-24 weeks 1

Dose Adjustments

For Drug Interactions

Reduce to 50 mg twice daily when co-administered with:

  • CYP3A4 inhibitors (e.g., erythromycin, diltiazem)
  • CYP2C19 inhibitors (e.g., omeprazole)

In Europe, cilostazol is contraindicated with these inhibitors; in the US, dose reduction is recommended 5

For Renal Impairment

The provided evidence does not specify dose adjustments for renal impairment, though protein binding is altered (27% higher free fraction) 4. Cilostazol is contraindicated in severe renal impairment 5

For Hepatic Impairment

Cilostazol is contraindicated in severe hepatic impairment 5. No specific dose adjustments are provided for mild-to-moderate hepatic disease in the available evidence.

Absolute Contraindication

Do not use cilostazol in patients with heart failure of any severity 1, 2, 1, 2, 3. This FDA black-box warning exists because other phosphodiesterase III inhibitors (milrinone, vesnarinone) increased mortality in heart failure patients 1, 3.

Clinical Considerations

  • Assess tolerance at 2-4 weeks: Common side effects include headache, diarrhea, abnormal stools, palpitations, and dizziness 1
  • Evaluate benefit at 3-6 months to determine if long-term therapy is warranted 3
  • Discontinuation rate: Approximately 20% of patients stop cilostazol within 3 months due to adverse effects 3
  • Many physicians start with 50 mg twice daily to minimize early side effects, then increase to 100 mg twice daily within 4 weeks 6

Duration of Therapy

While some physicians prescribe cilostazol for an average of 4 months, lifelong treatment may be appropriate for sustained symptom control 6. The drug improves maximal walking distance by 40-60% compared to placebo 1, 7, with benefits including improved quality of life and functional status 1, 3.

References

5
Research

Cilostazol: a review of its use in intermittent claudication.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003

Related Questions

What is the appropriate adult dosage of cilostazol for intermittent claudication?
What are the indications, recommended dosing, contraindications, common adverse effects, and monitoring recommendations for cilostazol?
What is the recommended adult tablet dose of cilostazol for intermittent claudication, and how should it be adjusted when the patient is taking CYP3A4 or CYP2C19 inhibitors or has symptomatic heart failure?
For a patient with peripheral arterial disease, should cilostazol be used instead of clopidogrel, and is it recommended as monotherapy or in combination with clopidogrel?
Can cilostazol be added to aspirin in a patient with peripheral arterial disease (PAD) and claudication and an ankle‑brachial index (ABI) of 0.4 while awaiting evaluation by a vascular specialist?
In a 5-year-old with a subtle, minimally displaced distal radius fracture on radiograph performed 5 days ago, are repeat radiographs indicated?
What alternative method can be used for corneal staining during an eye examination when fluorescein strips are unavailable?
For a 64‑year‑old patient with multilevel degenerative changes of the spine but no significant central canal narrowing or critical neuroforaminal narrowing, how should the imaging findings be interpreted?
In a 45-year-old woman with unilateral mandibular swelling, mild pedal edema, bow‑leg deformity, linear white gingival lines, and missing lower left jaw teeth, and essentially normal laboratory values, what is the likely diagnosis and what first‑line treatment and dosage should be administered?
How should I manage a blood pressure of 155/95 mm Hg in a patient currently taking losartan 50 mg and hydrochlorothiazide 12.5 mg?
What is the correct dosing of XOPENEX (levalbuterol) for children and adults?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.